XXresearch – Yeast Infections

What:A Phase 2, Open-label, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis

Who: Females 18 and older

Duration: 36 days

Name
First Last
Phone
Email
Are you a female, 18 years or older and pre-menopausal ?
Are you experiencing acute moderate to severe yeast infection symptoms?
Have you self treated in the past 48 hours?